Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.

被引：1
|
作者：
Kusumoto, Tetsuya
Egashira, Akinori
Sonoda, Hideto
Hashimoto, Kenkichi
Uehara, Hideo
Kusumoto, Eiji
Shinzato, Chiaki
Uchino, Keita
Sakaguchi, Yoshihisa
Ikejiri, Koji
Maehara, Yoshihiko
机构：
[1] Natl Kyushu Med Ctr, Dept Gastrointestinal Surg, Fukuoka, Fukuoka, Japan
[2] Natl Kyushu Med Ctr, Clin Res Ctr Canc Res Div, Fukuoka, Fukuoka, Japan
[3] Natl Kyusyu Med Ctr, Dept Med Oncol, Fukuoka, Fukuoka, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15540
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel
    Shitara, K.
    Matsuo, K.
    Takahari, D.
    Yokota, T.
    Shibata, T.
    Ura, T.
    Ito, S.
    Sawaki, A.
    Tajika, M.
    Kawai, H.
    Muro, K.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2403 - 2409
  • [22] NEUTROPENIA AS A PROGNOSTIC FACTOR IN ADVANCED GASTRIC CANCER PATIENTS UNDERGOING SECOND-LINE CHEMOTHERAPY WITH WEEKLY PACLITAXEL
    Shitara, K.
    Matsuo, K.
    Daisuke, T.
    Yokota, T.
    Ura, T.
    Ito, S.
    Sawaki, A.
    Tajika, M.
    Kawai, H.
    Muro, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 242 - 242
  • [23] Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer
    Fukuchi, Minoru
    Mochiki, Erito
    Ishiguro, Toru
    Ogura, Toshiro
    Sobajima, Jun
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2016, 36 (12) : 6699 - 6703
  • [24] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Mashiro Okunaka
    Daisuke Kotani
    Ken Demachi
    Akihito Kawazoe
    Takayuki Yoshino
    Toshikatsu Kawasaki
    Kohei Shitara
    BMC Cancer, 20
  • [25] Comparison of efficacy among nab-paclitaxel, paclitaxel and irinotecan monotherapies as the second-line chemotherapy following S-1-containing regimens in patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Egashira, Akinori
    Hashimoto, Kenkichi
    Kusumoto, Eiji
    Tsutsumi, Norifumi
    Ota, Mitsuhiko
    Sakaguchi, Yoshihisa
    Ikejiri, Koji
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Kawasaki, Toshikatsu
    Shitara, Kohei
    BMC CANCER, 2020, 20 (01)
  • [27] Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer
    K. Zhou
    F. Wen
    P. Zhang
    J. Zhou
    H. Chen
    H. Zheng
    Y. Yang
    Q. Li
    Clinical and Translational Oncology, 2017, 19 : 1117 - 1124
  • [28] EFFICACY AND COST-EFFECTIVENESS OF SECOND-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER
    Zhou, K.
    VALUE IN HEALTH, 2017, 20 (05) : A92 - A92
  • [29] EFFICACY AND COST-EFFECTIVENESS OF SECOND-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER
    Zhou, K.
    VALUE IN HEALTH, 2017, 20 (09) : A871 - A871
  • [30] Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer
    Zhou, K.
    Wen, F.
    Zhang, P.
    Zhou, J.
    Chen, H.
    Zheng, H.
    Yang, Y.
    Li, Q.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (09): : 1117 - 1124
12345